INSYS
Pre-Approval PRO BETAInactive Company
No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 4/23/2018
Pipeline by Phase
Therapeutic Focus
Clinical Trials (23)
Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
Started: 1/8/2016
Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome
Started: 12/30/2017
Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome
Started: 12/30/2017
Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting
Started: 12/30/2017
Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Started: 1/29/2016
Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Started: 2/24/2015
Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis
Started: 10/1/2009
Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain
Started: 9/12/2017
Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
Started: 1/27/2016
Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer
Started: 6/1/2010
Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain
Started: 12/1/2016
Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer
Started: 4/1/2010
Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer
Started: 3/1/2008
A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers
Started: 4/23/2018
A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers
Started: 8/7/2017
Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders
Started: 4/13/2015
Fentanyl Sublingual Spray in Opioid Naive Participants
Started: 1/1/2016
Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects
Started: 10/1/2015
Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
Started: 6/1/2015
A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users
Started: 2/1/2014
Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions
Started: 10/1/2011
Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors
Started: 2/1/2008